Blood cancers, Myeloma
Results
Phase 3
This trial looked at adding venetoclax to bortezomib and dexamethasone for myeloma. It was for people whose myeloma had come back or whose treatment had stopped working.
This trial was open for people to join between 2016 and 2017. The team published the results in 2020.
Recruitment start: 8 November 2016
Recruitment end: 19 May 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Rakesh Popat
AbbVie
Genentech
Last reviewed: 20 Oct 2021
CRUK internal database number: 14531
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
